In:
Journal of the American Academy of Orthopaedic Surgeons, Ovid Technologies (Wolters Kluwer Health)
Abstract:
The Centers for Medicare and Medicaid Services removed total hip arthroplasty (THA) from the inpatient-only list but continued to classify admissions as inpatient if they include two midnights, complicating care if an outpatient THA requires extended hospitalization. This study evaluates risk factors of patients undergoing outpatient-designated THA with a length of stay (LOS) ≥ 2 days. Methods: A total of 17,063 THA procedures designated as outpatient in the National Surgical Quality Improvement Program database between 2015 and 2020 were stratified by LOS 〈 2 days (n = 2,294, 13.4%) and LOS ≥ 2 days (n = 14,765, 86.6%). Demographics, comorbidities, and outcomes were compared by univariate analysis. Multivariable regression analysis identified predictors of LOS ≥ 2 days. Results: Outpatients with extended LOS were older (mean 65.3 vs. 63.5 years; P 〈 0.01); were more likely to have body mass index (BMI) 〉 35 (24.0 vs. 17.8%; P 〈 0.01); and had higher incidences of smoking (15.1% vs. 10.3%; P 〈 0.01), diabetes (15.4% vs. 9.9%; P 〈 0.01), chronic obstructive pulmonary disease (4.4% vs. 2.3%; P 〈 0.01), and hypertension (57.6% vs. 49.2%; P 〈 0.01). Patients with LOS ≥ 2 days had a higher incidence of surgical site infection ( P 〈 0.01), hospital readmission ( P 〈 0.01), and revision surgery ( P 〈 0.01) over 30 days. Multivariable analysis demonstrated advanced age, female sex, African American race, Hispanic ethnicity, diabetes, smoking, and hypertension were independent risk factors for LOS ≥ 2 days. Conclusion: Despite removal from the inpatient-only list, a subset of outpatient THA remains at risk of an extended LOS. This study informs surgeons on the relevant risk factors of extended stay, enabling early inpatient preauthorization.
Type of Medium:
Online Resource
ISSN:
1067-151X
,
1940-5480
DOI:
10.5435/JAAOS-D-23-00841
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2024
